Learn More About TRIP’s Active Clinical TrialsClick Here for Details

Treatment-Resistant Depression

Ongoing Clinical Research Study

There is an ongoing psychedelic clinical research study evaluating safety and efficacy of intranasal study drug for patients with treatment resistant depression.

If eligible, study participants will be expected to: 

  • Abstain from illicit drugs for the duration of the trial
  • Attend all study visits and follow instructions from the study doctor

Study related examinations will be at no cost to you.

Find out if participating in our medical research study may be an option for you.

Minimum Requirements

You may be eligible to join this study if:

  • You are 22-75 years of age
  • You have failed to respond to an adequate dose and duration of at least 2 medicines for depression
  • You are willing and able to discontinue any currently-taken antidepressants

Contact Us

Learn more about your treatment options.